STEVE OROSZ

Hanover Family Builders

Steve Orosz is the Co-President of Hanover Family Builders, a production homebuilder in Central Florida.  Steve has 17 years of homebuilding and residential land development experience.  Under the role of Co-President, Steve specializes in the accounting and financial reporting/analysis, human resources, information technology, and general operations of the company.  In 2019, Hanover Family Builders was ranked by the Orlando Business Journal as the fastest growing private company in Central Florida.   

Steve started his financial career in public accounting with Deloitte and Touche performing Audit and Advisory Services in Philadelphia.  In 2007, the Orosz Family established Hanover Capital Partners, a real estate investment company. Steve and other members of the Orosz Family also founded Royal Oak Homes, a division of Hanover Capital Partners, of which Steve was later named Co-President.  In 2013, Royal Oak Homes was named the fastest homebuilding company in the Country by Builder Magazine, and the fastest growing private company in Central Florida by the Orlando Business Journal. 

In 2014, Royal Oak Homes was sold to AV Homes, Inc (NYSE: AVHI) and he and his brother, Matt, continued their roles as Co-Presidents.  From 2014 to 2017, under the Orosz leadership, the division closed in excess of 1,100 homes annually as the 3rd largest homebuilder in Central Florida with annual revenues exceeding $375 million.  

Steve has experience in the acquisition and development of over 40 residential communities totaling over 7,000 lots. In addition, he also has worked with multiple regional financial institutions to obtain/manage more than $325 million in financing for both horizontal and vertical residential construction.

He is a graduate of Villanova University with a Bachelor of Science in Accounting and also has a Masters in Accounting degree from the University of Central Florida.  Steve is Vice-President of the Orosz Family Foundation which primarily contributes to further education initiatives and diabetes research.